Home › Funds › Miramar Capital, LLC › ABT

Miramar Capital, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Miramar Capital, LLC reported holding 138,737 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$12.6M, representing 2.77% of its reported portfolio and ranking #22 among its reported holdings. Miramar Capital, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)138.74K sh
Reported value held$12.59M
Portfolio Weight2.77%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Miramar Capital, LLC's ABT position evolved

Miramar Capital, LLC first disclosed a stake in ABT in Q3 2023 at 114,777 shares (US$11.1M). The position peaked in Q2 2026 at 138,737 shares, worth US$12.6M. Across 12 filings, Miramar Capital, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 138,737 shares valued at US$12.6M — an increase of 33,524 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2024 (shares were roughly flat over the following quarter), a 30% increase in Q1 2026 (shares fell 11% over the following quarter), a 32% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 114.78K $11.12M New
Q4 2023 110.82K $12.20M Reduce
Q1 2024 110.52K $11.73M Hold
Q2 2024 112.21K $11.66M Add
Q3 2024 78.75K $8.98M Reduce
Q4 2024 79.03K $8.94M Hold
Q1 2025 76.55K $10.15M Reduce
Q2 2025 76.67K $10.43M Hold
Q3 2025 80.97K $10.84M Add
Q4 2025 81.08K $10.16M Hold
Q1 2026 105.21K $10.80M Add
Q2 2026 138.74K $12.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Miramar Capital, LLC held ABT?

Miramar Capital, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Miramar Capital, LLC's current position in ABT?

As of Q2 2026, Miramar Capital, LLC holds 138.74K shares of ABT (ABBOTT LABORATORIES), valued at $12.59M, representing 2.77% of its reported portfolio and ranking #22.

Has Miramar Capital, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Miramar Capital, LLC increased its position in ABT. The position peaked in Q2 2026 at 138.74K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.